27 July 2023
27 July 2023
According to consensus forecasts from GlobalData’s Pharma Intelligence Centre, Xdemvy is estimated to earn $652m in global sales in 2029.
The review was triggered after cases of alleged suicidal or self-harming thoughts were reported following the use of the drugs.
This partnership represents an extension of the partnership formed by AbbVie and Scripps Research in 2019 to develop new therapeutics.
Bevacizumab biosimilars have since achieved notable commercial success, with global sales surpassing $2.2bn collectively.
Intrommune Therapeutics has completed the last patient last visit for its desensitisation candidate INT301.
The funding supports Nexo's platform, which uses covalent ligand discovery and chemical biology to develop new cancer therapies.
Space offers a unique manufacturing environment because it exists in a near-vacuum state, has higher radiation levels, and very weak gravity.
In the global pharmaceutical industry, there were 92 private equity deals announced in Q2 2023, worth a total value of $17.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
